Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Flavimax

PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Provider of liposomal-antioxidant drugs designed to treat tissue regeneration and gestosis of pregnant women. The company's drugs are used in the gynecology for the relief of inflammation and tissue regeneration, as well as in Perinatology in the treatment of gestosis of pregnant women and the prevention of premature birth, enabling patients to begin treatment more quickly, resulting in a higher likelihood of a successful treatment.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Ulica Pobedy, 28
  • Reutov
  • Moscow, 143968
  • Russia

+7 8 (000) 000-00-00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Flavimax’s full profile, request a free trial.

Flavimax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Flavimax Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
VEB Innovations Not-For-Profit Venture Capital Minority 000 0000 000000 0